Efficacy of As-Needed Nalmefene in Alcohol-Dependent Patients with at Least a High Drinking Risk Level: Results from a Subgroup Analysis of Two Randomized Controlled 6-Month Studies-Reference-Cited by-同舟云学术

Efficacy of As-Needed Nalmefene in Alcohol-Dependent Patients with at Least a High Drinking Risk Level: Results from a Subgroup Analysis of Two Randomized Controlled 6-Month Studies

Published:2013-07-19 Issue:5 Volume:48 Page:570-578
ISSN:0735-0414
Container-title:Alcohol and Alcoholism
language:en
Short-container-title:Alcohol and Alcoholism

Author:

van den Brink W.,Aubin H.-J.,Bladstrom A.,Torup L.,Gual A.,Mann K.

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/alcalc/article-pdf/48/5/570/17047344/agt061.pdf

Reference21 articles.

1. Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers: Partial Kappa Opioid Agonist Activity?

2. Screening in brief intervention trials targeting excessive drinkers in general practice: systematic review and meta-analysis

3. Alcohol treatment utilization: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions

4. Effectiveness and cost-effectiveness of a stepped care intervention for alcohol use disorders in primary care: pilot study

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NALMEFENE;Prescriber's Guide;2024-04-18

2. Prazosin and cyproheptadine in combination in the treatment of alcohol use disorder: A randomized, double‐blind, placebo‐controlled trial;Addiction;2024-04-10

3. Efficacy and safety of alcohol reduction pharmacotherapy according to treatment duration in patients with alcohol dependence or alcohol use disorder: A systematic review and network meta‐analysis;Addiction;2024-01-03

4. Repurposing drugs for treatment of alcohol use disorder;International Review of Neurobiology;2024

5. Adjunctive Medication Management and Contingency Management to enhance adherence to acamprosate for alcohol dependence: the ADAM trial RCT;Health Technology Assessment;2023-10